NEWS
Tags: 

RaQualia selects Miner3D for its visual data analysis platform

RaQualia Pharma will use Miner3D as its main R&D data analytics platform.  

RaQualia, a pharmaceutical research and development company, is a spin-off of drug maker giant Pfizer. The company focuses on pain and gastrointestinal therapeutic areas and manages six drug discovery programs.  

Miner3D helps RaQualia’s scientists and researchers to better understand vast amounts of scientific data, improve leads identification and speed up research and development processes.

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

Sophia Ktori investigates the use of informatics software to increase data integrity in the laboratory

Feature

Tim Gillett reports from PRACEDays 2016, held in May in the city of Prague

Feature

Robert Roe investigates the motivation behind the architectural changes to Europes fastest supercomputer, Piz Daint, housed at the Swiss National Computing Centre

Feature

Robert Roe discusses the merits of the latest storage technologies, including a push by storage providers to develop end-to-end platforms featuring intelligent data management systems

Feature

As AMD launches its latest FirePro GPU, Robert Roe investigates a new suite of open-source tools, released by the company that convert code from CUDA into C++